Ozawa Clare

CIK 00017467421 companyPRINCETON, NJ

SEC Profile

Transactions

Companies

Filings

CIK

0001746742

Recent Transactions

50 trades

Disposition to Issuer
Oyster Point Pharma, Inc.
Common Stock
2023-01-03−3,573→ 0 total
Disposition from Tender
Oyster Point Pharma, Inc.
Common Stock
2023-01-03−1,003,658→ 0 total
Disposition to Issuer
Oyster Point Pharma, Inc.
Common Stock
2023-01-03−11,064→ 3,573 total
Disposition from Tender
Oyster Point Pharma, Inc.
Common Stock
2023-01-03−414,607→ 0 total
Disposition from Tender
Oyster Point Pharma, Inc.
Common Stock
2023-01-03−2,465→ 0 total
Disposition from Tender
Oyster Point Pharma, Inc.
Common Stock
2023-01-03−2,236,888→ 0 total
Disposition to Issuer
Oyster Point Pharma, Inc.
Stock Option (Right to Buy)
2023-01-03−5,359→ 0 total
Disposition to Issuer
Oyster Point Pharma, Inc.
Stock Option (Right to Buy)
2023-01-03−5,199→ 0 total
Award
Oyster Point Pharma, Inc.
Stock Option (Right to Buy)
2022-06-06+5,359→ 5,359 total
Award
Oyster Point Pharma, Inc.
Common Stock
2022-06-06+3,573→ 14,637 total
Other
Oyster Point Pharma, Inc.
Common Stock
2022-01-05−200,213→ 414,607 total
Other
Oyster Point Pharma, Inc.
Common Stock
2022-01-05+51,556→ 51,556 total
Other
Oyster Point Pharma, Inc.
Common Stock
2022-01-05+120→ 11,064 total
Other
Oyster Point Pharma, Inc.
Common Stock
2022-01-05−51,556→ 0 total
Other
Oyster Point Pharma, Inc.
Common Stock
2022-01-05−1,261→ 2,465 total
Other
Oyster Point Pharma, Inc.
Common Stock
2021-12-21−51,556→ 0 total
Other
Oyster Point Pharma, Inc.
Common Stock
2021-12-21−200,213→ 614,820 total
Other
Oyster Point Pharma, Inc.
Common Stock
2021-12-21−1,261→ 3,726 total
Other
Oyster Point Pharma, Inc.
Common Stock
2021-12-21+120→ 10,944 total
Other
Oyster Point Pharma, Inc.
Common Stock
2021-12-21+51,556→ 51,556 total
Sale
Oyster Point Pharma, Inc.
Common Stock
2021-10-18$15.09/sh−1,531→ 4,987 total
Sale
Oyster Point Pharma, Inc.
Common Stock
2021-10-18$14.63/sh−1,912→ 6,518 total
Sale
Oyster Point Pharma, Inc.
Common Stock
2021-10-18$14.63/sh−303,614→ 1,057,976 total
Sale
Oyster Point Pharma, Inc.
Common Stock
2021-10-18$15.09/sh−242,943→ 815,033 total
Award
Oyster Point Pharma, Inc.
Common Stock
2021-06-07+3,466→ 10,824 total
Award
Oyster Point Pharma, Inc.
Stock Option (Right to Buy)
2021-06-07+5,199→ 5,199 total
Other
Oyster Point Pharma, Inc.
Common Stock
2021-05-12−2,018→ 8,430 total
Other
Oyster Point Pharma, Inc.
Common Stock
2021-05-12−320,340→ 1,361,590 total
Other
Oyster Point Pharma, Inc.
Common Stock
2021-05-12+82,486→ 82,486 total
Other
Oyster Point Pharma, Inc.
Common Stock
2021-05-12−82,486→ 0 total
Other
Oyster Point Pharma, Inc.
Common Stock
2021-05-12+193→ 7,358 total
Other
Oyster Point Pharma, Inc.
Common Stock
2021-03-26−82,491→ 0 total
Other
Oyster Point Pharma, Inc.
Common Stock
2021-03-26+82,491→ 82,491 total
Other
Oyster Point Pharma, Inc.
Common Stock
2021-03-26−320,368→ 1,681,930 total
Other
Oyster Point Pharma, Inc.
Common Stock
2021-03-26−1,990→ 10,448 total
Other
Oyster Point Pharma, Inc.
Common Stock
2021-03-26+193→ 7,165 total
Other
Oyster Point Pharma, Inc.
Common Stock
2021-02-17+372→ 6,972 total
Other
Oyster Point Pharma, Inc.
Common Stock
2021-02-17−325,000→ 2,236,888 total
Other
Oyster Point Pharma, Inc.
Common Stock
2021-02-17−6,500→ 0 total
Other
Oyster Point Pharma, Inc.
Common Stock
2021-02-17+5,607→ 5,607 total
Other
Oyster Point Pharma, Inc.
Common Stock
2021-02-17+6,500→ 6,500 total
Other
Oyster Point Pharma, Inc.
Common Stock
2021-02-17−5,607→ 0 total
Award
Oyster Point Pharma, Inc.
Common Stock
2020-06-08+6,600→ 6,600 total
Conversion
Oyster Point Pharma, Inc.
Common Stock, par value $0.001 per share
2019-11-04+1,941,500→ 1,941,500 total
Conversion
Oyster Point Pharma, Inc.
Common Stock, par value $0.001 per share
2019-11-04+495,388→ 2,436,888 total
Conversion
Oyster Point Pharma, Inc.
Common Stock, par value $0.001 per share
2019-11-04+566,158→ 566,158 total
Conversion
Oyster Point Pharma, Inc.
Series A Convertible Preferred Stock
2019-11-04−1,941,500→ 0 total
Conversion
Oyster Point Pharma, Inc.
Series B Convertible Preferred Stock
2019-11-04−495,388→ 0 total
Conversion
Oyster Point Pharma, Inc.
Series B Convertible Preferred Stock
2019-11-04−566,158→ 0 total
Purchase
Oyster Point Pharma, Inc.
Common Stock, par value $0.001 per share
2019-11-04$16.00/sh+125,000→ 2,561,888 total

Companies

Oyster Point Pharma, Inc.
Director

Recent Filings

Address

C/O OYSTER POINT PHARMA, INC. 202 CARNEGIE CENTER, SUITE 109

PRINCETON, NJ, 08540

View on SEC.gov